Published in
American Society of Hematology, Blood, 6(126), p. 733-738, 2015
DOI: 10.1182/blood-2015-01-622084
Links
Tools
Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: A subset analysis of NCIC CTG LY12
Journal article published in 2015 by
John Kuruvilla 
,
David A. MacDonald,
C. Tom Kouroukis,
C. Tom Kouroukis,
Matthew Cheung,
Harold J. Olney,
A. Robert Turner,
A. Robert Turner,
Peter Anglin,
Matthew Seftel,
Walid Sabry Ismail,
Stefano Luminari,
Stephen Couban,
Tara Baetz,
Ralph M. Meyer
and other authors.
,
David A. MacDonald,
C. Tom Kouroukis,
C. Tom Kouroukis,
Matthew Cheung,
Harold J. Olney,
A. Robert Turner,
A. Robert Turner,
Peter Anglin,
Matthew Seftel,
Walid Sabry Ismail,
Stefano Luminari,
Stephen Couban,
Tara Baetz,
Ralph M. Meyer
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Patients with relapsed or refractory transformed indolent lymphoma and DLBCL have similar outcomes with salvage therapy and ASCT. This therapy should be considered the standard of care for previously treated transformed indolent lymphoma.